Comparative Study of Alternative Antiandrogen (AA) Therapy and Early Initiating of Enzalutamide for Castration-resistant Prostate Cancer (CRPC) After Combined Androgen Blockade (CAB) Therapy.

PHASE2CompletedINTERVENTIONAL

Enrollment

104

Participants

Timeline

Start Date

December 31, 2014

Primary Completion Date

September 30, 2018

Study Completion Date

January 22, 2019

Conditions

Castration-resistant Prostate Cancer

Interventions

DRUG

Enzalutamide

DRUG

Flutamide

Trial Locations (1)

Osaka City University Graduate School of Medicine, Osaka